The Company is in search of a Vice President for Early Pipeline Delivery, a pivotal role dedicated to leading a new team within the Pipeline Delivery organization. The successful candidate will be responsible for designing and implementing an early pipeline operating model, establishing efficient ways of working, and leading cross-functional capability building to accelerate the speed to Proof-of-Concept (PoC) across the company's early development portfolio. This role demands a seasoned executive with a strong background in clinical operations, particularly in early-stage study management, and a proven track record of team and operational function scaling. The Vice President will also be instrumental in driving the execution of priority studies, integrating adaptive execution practices, and applying AI-enabled tools to enhance feasibility and enrollment forecasting. Applicants for the Vice President position should hold an MSc, MBA, PhD, or equivalent in a relevant discipline, with a preference for those with over 20 years of industry experience. The role requires a leader with a builder's mindset, capable of thriving in a growth environment and energized by the opportunity to shape new organizational capabilities. Key qualifications include experience with first-in-human and healthy-volunteer study designs, a strong operational and analytical background, and the ability to influence senior leadership. The ideal candidate will have a history of driving cross-functional alignment, be adept at using data for continuous improvement, and have a strong focus on proactive risk anticipation. Familiarity with AI-enabled tools for clinical forecasting is a plus, and the candidate should be prepared to support the delivery of complex, novel study types in emerging therapeutic areas.

Hiring Company

Alnylam Pharmaceuticals